Get to know others with similar interests as you. Choose the topic most important to your business needs. You'll sit with 10 - 20 others seeking similar opportunities to debate the advantages and challenges assocatied with your chosen area, and make more connections!

#1 Valuation Strategies To Optimize Deal Terms And Structures
Kelly P. Powell, VP, Corporate Development, Orexigen Therapeutics

• Exploring valuation techniques to arrive at preferred deal terms (e.g. comparables, invested capital, discounted cash flow, etc.)
• When to use various techniques, as well as associated pitfalls
• How to use financial models to generate mutually beneficial deal structures
• Considerations for harmonizing your qualitative and quantitative partnering objectives

#2 Quality Systems Management From Concept To Production: Are You Ready?
Christopher Gambale, President, Global GxP Solutions

• Building or modifying quality systems to incorporate new technology and new scientific platforms - Managing vendor quality risks through effective audit programs
• Improving speed to market through effective and efficient launches in a compliant manner
• Addressing existing Regulatory enforcement actions hamping your innovation and preventing new ones
• Preparation to move from an R&D setting or paper based system to an electronic system
• Essential elements necessary for a successful system implementation, cultural adoption, and long-term success in a complaint quality management system
• Quality strategy and project management

#3 Alliance Management Best Practices
Gerry McCluskey, VP, Business Development and Alliance Management, Horizon Pharma

• How can BD and alliance management functions work most effectively together?
• How to avoid common pitfalls in alliance management
• Exploiting alliance management opportunities
  

#4 The Changing Face Of Venture Capital
Priyanka Rohatgi, Director, Baxter Ventures

• How has traditional venture capital changed over the past year, and what are expectations for the near- and far-term future?
• Exploring the emergence of venture capital groups associated with large provider organizations; what are their objectives in the current biopharma space?
• Discovering how the relationships among Big Pharma, biotechs, and VC are evolving

#5 In-Licensing: Winning Deals In A Highly Competitive Environment

Kalpana Gupta, Director of Business Development, Regeneron